These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Merging memantine and ferulic acid to probe connections between NMDA receptors, oxidative stress and amyloid-β peptide in Alzheimer's disease. Rosini M; Simoni E; Caporaso R; Basagni F; Catanzaro M; Abu IF; Fagiani F; Fusco F; Masuzzo S; Albani D; Lanni C; Mellor IR; Minarini A Eur J Med Chem; 2019 Oct; 180():111-120. PubMed ID: 31301562 [TBL] [Abstract][Full Text] [Related]
8. Memantine protects rat cortical cultured neurons against beta-amyloid-induced toxicity by attenuating tau phosphorylation. Song MS; Rauw G; Baker GB; Kar S Eur J Neurosci; 2008 Nov; 28(10):1989-2002. PubMed ID: 19046381 [TBL] [Abstract][Full Text] [Related]
9. Time-dependent effect of oligomeric amyloid-β (1-42)-induced hippocampal neurodegeneration in rat model of Alzheimer's disease. Karthick C; Nithiyanandan S; Essa MM; Guillemin GJ; Jayachandran SK; Anusuyadevi M Neurol Res; 2019 Feb; 41(2):139-150. PubMed ID: 30453864 [TBL] [Abstract][Full Text] [Related]
10. [Glutamate-related excitotoxicity neuroprotection with memantine, an uncompetitive antagonist of NMDA-glutamate receptor, in Alzheimer's disease and vascular dementia]. Tanović A; Alfaro V Rev Neurol; 2006 May 16-31; 42(10):607-16. PubMed ID: 16703529 [TBL] [Abstract][Full Text] [Related]
11. Synapses, NMDA receptor activity and neuronal Aβ production in Alzheimer's disease. Bordji K; Becerril-Ortega J; Buisson A Rev Neurosci; 2011; 22(3):285-94. PubMed ID: 21568789 [TBL] [Abstract][Full Text] [Related]
13. Calcium flux-independent NMDA receptor activity is required for Aβ oligomer-induced synaptic loss. Birnbaum JH; Bali J; Rajendran L; Nitsch RM; Tackenberg C Cell Death Dis; 2015 Jun; 6(6):e1791. PubMed ID: 26086964 [TBL] [Abstract][Full Text] [Related]
14. The basal forebrain cholinergic system in aging and dementia. Rescuing cholinergic neurons from neurotoxic amyloid-β42 with memantine. Nyakas C; Granic I; Halmy LG; Banerjee P; Luiten PG Behav Brain Res; 2011 Aug; 221(2):594-603. PubMed ID: 20553766 [TBL] [Abstract][Full Text] [Related]
15. The neuropharmacological basis for the use of memantine in the treatment of Alzheimer's disease. Rogawski MA; Wenk GL CNS Drug Rev; 2003; 9(3):275-308. PubMed ID: 14530799 [TBL] [Abstract][Full Text] [Related]
16. Dysfunction of NMDA receptors in Alzheimer's disease. Zhang Y; Li P; Feng J; Wu M Neurol Sci; 2016 Jul; 37(7):1039-47. PubMed ID: 26971324 [TBL] [Abstract][Full Text] [Related]
17. Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system--too little activation is bad, too much is even worse. Parsons CG; Stöffler A; Danysz W Neuropharmacology; 2007 Nov; 53(6):699-723. PubMed ID: 17904591 [TBL] [Abstract][Full Text] [Related]
18. Amyloid β, glutamate, excitotoxicity in Alzheimer's disease: are we on the right track? Esposito Z; Belli L; Toniolo S; Sancesario G; Bianconi C; Martorana A CNS Neurosci Ther; 2013 Aug; 19(8):549-55. PubMed ID: 23593992 [TBL] [Abstract][Full Text] [Related]
19. Abeta oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine. De Felice FG; Velasco PT; Lambert MP; Viola K; Fernandez SJ; Ferreira ST; Klein WL J Biol Chem; 2007 Apr; 282(15):11590-601. PubMed ID: 17308309 [TBL] [Abstract][Full Text] [Related]
20. NMDA-antagonism (memantine): an alternative pharmacological therapeutic principle in Alzheimer's and vascular dementia. Koch HJ; Szecsey A; Haen E Curr Pharm Des; 2004; 10(3):253-9. PubMed ID: 14754385 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]